These funds will speed up product development as it plans to unveil additional platform capabilities in the new year. Tiger Global, General Catalyst, Drive Capital, Silicon Valley Bank, GV, Sequoia Capital Global Equities, Dragoneer Investment Group and Transformation Capital Partners
Recursion is an artificial intelligence drug discovery company, The funds will help Recursion fuel the clinical development of its therapy.peutic pipeline, and support continued investment into the development of its technology. Leaps by Bayer, Casdin Capital, Catalio Capital Management, Laurion Capital Management, Samsara BioCapital and others. The core of Alto’s digital pharmacy business is a tech-enabled platform for free, same-day medication delivery. Softbank's Vision Fund 2, Greanoaks Capital, Jackson Square Ventures and othersĪlto has not shared its plans for the funds. The ClassPass platform allows users to sign up for a single subscription membership that allows them to participate in local fitness classes in exchange for credits. The company said that the new funds will help further scale its platform internationally. Its platform combines quantum physics, AI and cloud computing algorithms to assess how drugs react at a molecular level in order to help pharmaceuticals progress through clinical trials. XtalPi plans to use this funding to help make the pharmaceutical R&D process more efficient by expanding its ID4 platform. SoftBank Vision Fund 2, PICC Capital, Morningside,Tencent, Sequoia China, China Life and SIG Additionally, the tech-enabled company runs a consumer-minded platform consisting of web tools and a mobile app. and currently offers individual, family and Medicare Advantage plans. It operates in 43 markets across 13 states in the U.S. These funds, in addition to existing capital, will be used to help the company expand into new geographies, Bright Health said. Rowe Price Associates and Blackstone, NEA, Bessemer Venture Partners and Greenspring Associates. Verily serves as Alphabet’s research arm that develops tools and devices to collect, organize and activate health data. The investments will be used to expand some of Verily’s leading commercial businesses, such as Project Baseline. CompanyĪlphabet, Silver Lake, Temasek, Ontario Teachers' Pension Plan and others The companies' names also include links to our initial coverage of the raise. These entries are ordered by size with multiple raises by the same company broken out into separate entries.
SOURCES DIDI CHINABASED LINKDOC US FULL
To see our entire breakdown, read on below for the full list of funding news MobiHealthNews tracked in 2020. The year's raises were head and shoulders above its predecessors, which logged 251 announcements for $7.2 billion (2019) and 244 rounds for $7.7 billion (2018). That last group bankrolled 372 funding rounds for 351 companies, and by MobiHealthNews' count pumped about $13.8 billion into the digital health sector. In a calendar year that didn't adhere to anyone's expectations, digital health and health tech found unprecedented interest from patients, providers and investors alike.
Verily led the pack here with a late-breaking $700 million raise, but the last few weeks also saw noteworthy buzzer-beaters from Bright Health ($500 million) Olive ($225.5 million), Everlywell ($175 million) and Cityblock Health ($160 million).īig fundraising numbers were also the story of 2020 as a whole. By MobiHealthNews' tally, the last three months have hosted at least 92 digital health funding rounds totalling just over $3.8 billion – a marked increase over Q4 2019's 55 raises of $1.7 billion.Īfter something of a cool start, digital health investors finished the fourth quarter of 2020 strong with a collection of nine-figure raises from well-known health tech names.
0 kommentar(er)
